UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 411

Sortiert nach

Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2018-10, Vol.29 (Supplement_4), p.iv19-iv29

2018

Link zum Volltext

Verfügbarkeit prüfen

Radiotherapy and anti-PD-1/PD-L1 combinations in lung cancer: building better translational research platforms

Annals of oncology, 2018-02, Vol.29 (2), p.301-310

2018

Link zum Volltext

Verfügbarkeit prüfen

Turning Radiotherapy into an Effective Systemic Anti-cancer Treatment in Combination with Immunotherapy

Clinical oncology (Royal College of Radiologists (Great Britain)), 2015-12, Vol.27 (12), p.696-699

Illidge, T

2015

Link zum Volltext

Verfügbarkeit prüfen

Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2014-09, Vol.25 Suppl 3, p.iii70-iii75

2014

Link zum Volltext

Verfügbarkeit prüfen

SP-0556: Radiotherapy and immunotherapy combinations - unlocking the potential

Radiotherapy and oncology, 2014, Vol.111, p.S217-S218

Illidge, T

2014

Link zum Volltext

Verfügbarkeit prüfen

Balancing Risks in Developing a Personalised Approach to the Treatment of Early Hodgkin Lymphoma: Have We Got the Balance Right?

Clinical oncology (Royal College of Radiologists (Great Britain)), 2015-08, Vol.27 (8), p.454-456

Illidge, T

2015

Link zum Volltext

Verfügbarkeit prüfen

The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma

Annals of oncology, 2022-03, Vol.33 (3), p.288-298

2022

Link zum Volltext

Verfügbarkeit prüfen

British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous lymphomas 2018

British journal of dermatology (1951), 2019-03, Vol.180 (3), p.496-526

2019

Link zum Volltext

Verfügbarkeit prüfen

The antitumor immune response generated by fractionated radiation therapy may be limited by tumor cell adaptive resistance and can be circumvented by PD-L1 blockade

Oncoimmunology, 2015-07, Vol.4 (7), p.e1016709-e1016709

2015

Link zum Volltext

Verfügbarkeit prüfen

Extranodal diffuse large B-cell lymphoma (DLBCL) and primary mediastinal B-cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2016-09, Vol.27 (suppl 5), p.v91-v102

2016

Link zum Volltext

Verfügbarkeit prüfen

Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers

British journal of cancer, 2011-08, Vol.105 (5), p.628-639

2011

Link zum Volltext

Verfügbarkeit prüfen

X. When should radiotherapy be used in lymphoma?

Annals of oncology, 2011, Vol.22 (suppl_4), p.iv57-iv60

Illidge, T

2011

Link zum Volltext

Verfügbarkeit prüfen

The Radiotherapy Learning Healthcare System – Working Together to Improve the Quality of Radiotherapy Nationally

Clinical oncology (Royal College of Radiologists (Great Britain)), 2022-06, Vol.34 (6), p.411-414

2022

Link zum Volltext

Verfügbarkeit prüfen

Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous t-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome)

Annals of oncology, 2014-09, Vol.25 (9), p.1807-1812

2014

Link zum Volltext

Verfügbarkeit prüfen

A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells

Leukemia, 2017-07, Vol.31 (7), p.1611-1621

2017

Link zum Volltext

Verfügbarkeit prüfen

SP-0683 Combining immunotherapy with radiotherapy

Radiotherapy and oncology, 2023-05, Vol.182, p.S573-S573

Illidge, T.

2023

Link zum Volltext

Verfügbarkeit prüfen

SP-0132 Manipulating the immune contexture to improve radiotherapy responses

Radiotherapy and oncology, 2021-08, Vol.161, p.S88-S88

Illidge, T.

2021

Link zum Volltext

Verfügbarkeit prüfen

Outcome and feasibility of radiotherapy bridging in large B-cell lymphoma patients receiving CD19 CAR T in the UK

British journal of haematology, 2024-04

2024

Link zum Volltext

Verfügbarkeit prüfen

Modeling the immunological response to clinically relevant radiotherapy in a murine prostate tumour model

European journal of cancer (1990), 2016-07, Vol.61, p.S214-S214

2016

Link zum Volltext

Verfügbarkeit prüfen

Recommendations for the clinical management of the elderly patient with malignant lymphoma

Annals of oncology, 2018-04, Vol.29 (4), p.1069-1070

2018

Link zum Volltext

Verfügbarkeit prüfen

Radiotherapy and Immunotherapy Combinations in Non-small Cell Lung Cancer: A Promising Future?

Clinical oncology (Royal College of Radiologists (Great Britain)), 2016-11, Vol.28 (11), p.726-731

2016

Link zum Volltext

Verfügbarkeit prüfen

Assessment of circulating biomarkers for potential pharmacodynamic utility in patients with lymphoma

British journal of cancer, 2011-02, Vol.104 (4), p.719-725

2011

Link zum Volltext

Verfügbarkeit prüfen

A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells

Leukemia, 2017-10, Vol.31 (10), p.2278-2278

2017

Link zum Volltext

Verfügbarkeit prüfen

U.K. consensus statement on safe clinical prescribing of bexarotene for patients with cutaneous T-cell lymphoma

British journal of dermatology (1951), 2013-01, Vol.168 (1), p.192-200

2013

Link zum Volltext

Verfügbarkeit prüfen

SP-0454 Trial design: early clinical studies and learning from the laboratory

Radiotherapy and oncology, 2019-04, Vol.133, p.S236-S236

Illidge, T.

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 411

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(386)
Mit Volltextzugriff
(384)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(209)
Life Sciences & Biomedicine
(196)
Humans
(171)
Oncology
(102)
Female
(57)
Biological And Medical Sciences
(51)
Hematology
(51)
Medical Sciences
(47)
Lymphoma
(45)
Male
(45)
Animals
(43)
Adult
(41)
Radiotherapy
(39)
Immunotherapy
(38)
Middle Aged
(36)
Treatment Outcome
(35)
Tumors
(34)
Aged
(32)
Hematology, Oncology And Palliative Medicine
(30)
Combined Modality Therapy
(27)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(64)
Clinical Oncology
(25)
Annals Of Oncology
(21)
British Journal Of Haematology
(18)
Journal Of Clinical Oncology
(18)
International Journal Of Radiation Oncology, Biology, Physics
(16)
Hematological Oncology
(11)
Leukemia & Lymphoma
(11)
European Journal Of Cancer
(10)
Lymphoma
(10)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Radiotherapy and anti-PD-1/PD-L1 combinations in lung cancer: building better translational research platforms

Turning Radiotherapy into an Effective Systemic Anti-cancer Treatment in Combination with Immunotherapy

Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

SP-0556: Radiotherapy and immunotherapy combinations - unlocking the potential

Balancing Risks in Developing a Personalised Approach to the Treatment of Early Hodgkin Lymphoma: Have We Got the Balance Right?

The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma

British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous lymphomas 2018

The antitumor immune response generated by fractionated radiation therapy may be limited by tumor cell adaptive resistance and can be circumvented by PD-L1 blockade

Extranodal diffuse large B-cell lymphoma (DLBCL) and primary mediastinal B-cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers

X. When should radiotherapy be used in lymphoma?

The Radiotherapy Learning Healthcare System – Working Together to Improve the Quality of Radiotherapy Nationally

Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous t-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome)

A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells

SP-0683 Combining immunotherapy with radiotherapy

SP-0132 Manipulating the immune contexture to improve radiotherapy responses

Outcome and feasibility of radiotherapy bridging in large B-cell lymphoma patients receiving CD19 CAR T in the UK

Modeling the immunological response to clinically relevant radiotherapy in a murine prostate tumour model

Recommendations for the clinical management of the elderly patient with malignant lymphoma

Radiotherapy and Immunotherapy Combinations in Non-small Cell Lung Cancer: A Promising Future?

Assessment of circulating biomarkers for potential pharmacodynamic utility in patients with lymphoma

A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells

U.K. consensus statement on safe clinical prescribing of bexarotene for patients with cutaneous T-cell lymphoma

SP-0454 Trial design: early clinical studies and learning from the laboratory

Suchergebnisse filtern